Current Pharmaceutical Design
Title:Editorial (Thematic Issue: Epigenetic Regulation and Human Diseases)
Volume: 20 Issue: 11
Author(s): Shi-Wen Jiang
Affiliation:
Export Options
About this article
Cite this article as:
Jiang Shi-Wen, Editorial (Thematic Issue: Epigenetic Regulation and Human Diseases), Current Pharmaceutical Design 2014; 20 (11) . https://dx.doi.org/10.2174/13816128113199990548
DOI https://dx.doi.org/10.2174/13816128113199990548 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The HIV Life Cycle: Multiple Targets for Antiretroviral Agents
Drug Design Reviews - Online (Discontinued) Structural, Functional and Therapeutic Aspects of Snake Venom Metalloproteinases
Mini-Reviews in Organic Chemistry Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses
Current Gene Therapy The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Current Pharmaceutical Design Interrelation of Major Depression and Antidepressant Transcriptomics
Current Psychopharmacology Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes
Current Diabetes Reviews Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome
Current Medicinal Chemistry - Cardiovascular & Hematological Agents miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry From CHD Susceptibility Genes to New Therapeutics
Current Pharmacogenomics Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
Current Vascular Pharmacology Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism New Strategies for Managing Anemia of Chronic Kidney Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Familial Combined Hyperlipidaemia: Under - Defined and Under - Diagnosed?
Current Vascular Pharmacology Fc Engineering to Improve the Function of Therapeutic Antibodies
Current Pharmaceutical Biotechnology The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Current Molecular Pharmacology Role of Calcium in Platelet Activation: Novel Insights and Pharmacological Implications
Medicinal Chemistry